Efficacy Assessment of Radiotherapy Alone Versus Combined Surgery and Radiotherapy for Ipsilateral Supraclavicular Lymph Node Metastasis in Breast Cancer: A Retrospective Study with Eight-Year Follow-Up Utilizing Propensity Score Matching - Report - MDSpire

Efficacy Assessment of Radiotherapy Alone Versus Combined Surgery and Radiotherapy for Ipsilateral Supraclavicular Lymph Node Metastasis in Breast Cancer: A Retrospective Study with Eight-Year Follow-Up Utilizing Propensity Score Matching

  • By

  • Chao Wei

  • Shuhua Zhou

  • Longyu Zhu

  • Jie Kong

  • Zimeng Gao

  • Danyang Wang

  • Deyou Kong

  • Andu Zhang

  • Shuo Pan

  • Kaiye Du

  • Dongxing Shen

  • Jun Zhang

  • Zhikun Liu

  • December 26, 2025

  • 0 min

Share

Efficacy Assessment of Radiotherapy Alone Versus Combined Surgery and Radiotherapy

Overview

This study evaluates the efficacy of radiotherapy alone compared to combined surgery and radiotherapy for patients with ipsilateral supraclavicular lymph node metastasis (ISLM) in breast cancer. The findings suggest that radiotherapy alone may provide comparable outcomes to the combined approach, highlighting the need for individualized treatment strategies.

Background

Breast cancer remains the most prevalent malignancy among women, with ISLM indicating a poor prognosis. The management of ISLM is complex, as it can be categorized into synchronous and metachronous types, and the optimal local treatment strategy remains debated. Understanding the efficacy of different treatment modalities is crucial for improving patient outcomes.

Data Highlights

No numerical data was provided in the source material.

Key Findings

  • ISLM is classified as locally advanced breast cancer, affecting 1-4% of cases.
  • Patients with ISLM often experience distant metastasis within one year, indicating a poor prognosis.
  • The study analyzed 326 patients with sISLM, comparing outcomes between radiotherapy alone and surgery plus radiotherapy.
  • Recent evidence suggests that radiotherapy alone may be as effective as combined surgery and radiotherapy for managing ISLM.
  • Contemporary guidelines recommend comprehensive regional nodal irradiation for node-positive disease.

Clinical Implications

Clinicians should consider the potential equivalence of radiotherapy alone compared to combined approaches for ISLM patients when making treatment decisions. This could lead to reduced surgical interventions and associated complications while maintaining effective cancer control.

Conclusion

The study underscores the importance of evaluating treatment modalities for ISLM in breast cancer, suggesting that radiotherapy alone may suffice in certain cases. Further research is warranted to refine treatment strategies for this patient population.

References

  1. The ASCO Post, 2020 -- Reduced Breast Cancer Mortality and Risk of Recurrence With Internal Mammary and Medial Supraclavicular Nodal Irradiation in Stage I to III Breast Cancer
  2. Surgical Intervention on Primary Tumors Enhances Survival in Breast Cancer Patients with Concurrent Ipsilateral Supraclavicular Lymph Node Metastasis, 2019
  3. Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice Guideline - PubMed
  4. The ASCO Post — Reduced Breast Cancer Mortality and Risk of Recurrence With Internal Mammary and Medial Supraclavicular Nodal Irradiation in Stage I to III Breast Cancer
  5. Journal of Gastroenterology — Outcomes of Surgical Intervention Versus Chemoradiotherapy Following Endoscopic Resection for pT1a-MM with Lymphovascular Invasion or pT1b Esophageal Squamous Cell Carcinoma: A Multicenter Propensity Score-Matched Analysis from Japan
  6. Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice Guideline - PubMed
  7. Chen et al. BMC Cancer (2024) 24:1572

Original Source(s)

Related Content